253 related articles for article (PubMed ID: 11841542)
1. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif.
Kanazawa N; Okazaki T; Nishimura H; Tashiro K; Inaba K; Miyachi Y
J Invest Dermatol; 2002 Feb; 118(2):261-6. PubMed ID: 11841542
[TBL] [Abstract][Full Text] [Related]
2. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif.
Bates EE; Fournier N; Garcia E; Valladeau J; Durand I; Pin JJ; Zurawski SM; Patel S; Abrams JS; Lebecque S; Garrone P; Saeland S
J Immunol; 1999 Aug; 163(4):1973-83. PubMed ID: 10438934
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell immunoactivating receptor, a novel C-type lectin immunoreceptor, acts as an activating receptor through association with Fc receptor gamma chain.
Kanazawa N; Tashiro K; Inaba K; Miyachi Y
J Biol Chem; 2003 Aug; 278(35):32645-52. PubMed ID: 12777403
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell immunoreceptors: C-type lectin receptors for pattern-recognition and signaling on antigen-presenting cells.
Kanazawa N
J Dermatol Sci; 2007 Feb; 45(2):77-86. PubMed ID: 17046204
[TBL] [Abstract][Full Text] [Related]
5. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
[TBL] [Abstract][Full Text] [Related]
6. Regulation of immune responses through inhibitory receptors.
Long EO
Annu Rev Immunol; 1999; 17():875-904. PubMed ID: 10358776
[TBL] [Abstract][Full Text] [Related]
7. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
8. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
10. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2.
Kanazawa N; Tashiro K; Miyachi Y
Immunobiology; 2004; 209(1-2):179-90. PubMed ID: 15481152
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells.
Massoud AH; Yona M; Xue D; Chouiali F; Alturaihi H; Ablona A; Mourad W; Piccirillo CA; Mazer BD
J Allergy Clin Immunol; 2014 Mar; 133(3):853-63.e5. PubMed ID: 24210883
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor.
Christensen MD; Geisler C
Scand J Immunol; 2000 Jun; 51(6):557-64. PubMed ID: 10849365
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell inhibitory and activating immunoreceptors (DCIR and DCAR) in duck: Genomic organization and expression.
Guo X; Branton WG; Moon DA; Xia J; Macdonald MR; Magor KE
Mol Immunol; 2008 Sep; 45(15):3942-6. PubMed ID: 18657864
[TBL] [Abstract][Full Text] [Related]
14. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
[TBL] [Abstract][Full Text] [Related]
15. Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIR+ T cells.
Eklöw C; Makrygiannakis D; Bäckdahl L; Padyukov L; Ulfgren AK; Lorentzen JC; Malmström V
Ann Rheum Dis; 2008 Dec; 67(12):1742-9. PubMed ID: 18250113
[TBL] [Abstract][Full Text] [Related]
16. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
17. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway.
Lambert AA; Barabé F; Gilbert C; Tremblay MJ
Blood; 2011 Jun; 117(24):6589-99. PubMed ID: 21536857
[TBL] [Abstract][Full Text] [Related]
18. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith KM; Wu J; Bakker AB; Phillips JH; Lanier LL
J Immunol; 1998 Jul; 161(1):7-10. PubMed ID: 9647200
[TBL] [Abstract][Full Text] [Related]
19. KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity.
Han Y; Zhang M; Li N; Chen T; Zhang Y; Wan T; Cao X
Blood; 2004 Nov; 104(9):2858-66. PubMed ID: 15238421
[TBL] [Abstract][Full Text] [Related]
20. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE.
Katz HR; Vivier E; Castells MC; McCormick MJ; Chambers JM; Austen KF
Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10809-14. PubMed ID: 8855262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
